No Data
No Data
Henlius Biotech Advances Towards Privatisation
Shanghai Fosun Pharma Advances Henlius Privatization
Shanghai Henlius Biotech Schedules Key Board Meeting
Henlius (02696.HK) will hold a board of directors meeting on August 26 to approve the mid-year performance.
Henlius (02696.HK) announced on August 14th that the company will hold a board of directors meeting on August 26th, 2024 to consider and approve the interim performance announcement for the six months ending on June 30, 2024 and its publication, as well as to consider recommending the payment of interim dividends (if any).
HENLIUS: DATE OF BOARD MEETING
Shanghai Henlius Biotech Doses First Patient in Phase 2 Trial of Liver Cancer Drug Combo
No Data